Variable risk of second primary malignancy in multiple myeloma patients of different ethnic subgroups

Por Ailawadhi, S, Swaika, A, Razavi, P, Yang, D, Chanan-Khan, A
Publicado em 2014

Patterns of second primary malignancy risk in multiple myeloma patients before and after the introduction of novel therapeutics

Por Razavi, P, Rand, K A, Cozen, W, Chanan-Khan, A, Usmani, S, Ailawadhi, S
Publicado em 2013

Ultra-deep next-generation sequencing of plasma cell-free DNA in patients with advanced lung cancers: results from the Actionable Genome Consortium

Por Li, B T, Janku, F, Jung, B, Hou, C, Madwani, K, Alden, R, Razavi, P, Reis-Filho, J S, Shen, R, Isbell, J M, Blocker, A W, Eattock, N, Gnerre, S, Satya, R V, Xu, H, Zhao, C, Hall, M P, Hu, Y, Sehnert, A J, Brown, D, Ladanyi, M, Rudin, C M, Hunkapiller, N, Feeney, N, Mills, G B, Paweletz, C P, Janne, P A, Solit, D B, Riely, G J, Aravanis, A, Oxnard, G R
Publicado no Ann Oncol (2019)